High-density lipoprotein levels are strongly associated with the recovery rate of insulin sensitivity during the acute phase of myocardial infarction: a study by euglycemic hyperinsulinemic clamp.
BACKGROUND
The decrease of insulin sensitivity (IS) during myocardial infarction (MI) is strongly associated with increased morbidity and mortality. Recent data suggest that in individuals under stable conditions, high-density lipoprotein (HDL) may improve IS. To date, the role of HDL in the modulation of IS in acute metabolic stress conditions such as MI remains unknown.


OBJECTIVE
To explore the association between plasma HDL-C and the change in IS during the acute phase of MI.


METHODS
Consecutive nondiabetic patients with ST-segment elevation MI (n = 22) underwent direct measurement of IS through the euglycemic hyperinsulinemic clamp on the first morning and on the fifth day after onset of MI. Patients were grouped according to HDL-C levels at admission above and below the median value (35 mg/dL).


RESULTS
At admission, there was no significant difference in baseline IS index, clinical, anthropometric, or treatment characteristics between low and high HDL groups. Between admission and fifth day, there was a decrease of 8% in IS index in the low HDL group and an 11% increase in the high HDL group (P = .001 for intragroup and P = .012 for intergroup difference). This difference remained significant after we controlled for the sex, age, waist circumference, triglycerides, baseline IS index, and statin dose during hospitalization.


CONCLUSIONS
This is the first study to provide evidence that plasma levels of HDL-C are strongly associated with the recovery rate of IS during the acute phase of MI.
Cardiology Division, State University of Campinas, 13084-971, Campinas, Sao Paulo, Brazil.
Luiz Sergio F
LS
Carvalho
Naiara V
NV
Martins
Filipe A
FA
Moura
Riobaldo M R
RM
Cintra
Osorio L R
OL
Almeida
Jose C
JC
Quinaglia e Silva
Andrei C
AC
Sposito
D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D001774:Blood Chemical Analysis; D005260:Female; D015309:Glucose Clamp Technique; D006760:Hospitalization; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007333:Insulin Resistance; D008075:Lipoproteins, HDL / Q000097:blood*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D012720:Severity of Illness Index; D012737:Sex Factors; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008075:Lipoproteins, HDL; D014280:Triglycerides